Back to search
FDAFDA · Food and drugs·Recall number Z-0637-2024

High Frequency Transport Phasitron Breathing Circuit Kit REF: A50605-D, Rx Only, CE 0123

Published January 24, 2024 · Recall initiated: December 12, 2023

Summary

FDA records medical device Class I recall Z-0637-2024, published January 24, 2024 and initiated December 12, 2023. Recalling firm: Percussionaire Corporation; Status: Ongoing; Reported quantity: 2145 units; Lot: UDI: (01)10849436000331/Lot # WO05216, WO05254, WO05321, WO05392, WO05559, WO05588, WO05684, WO05749, WO05896, WO05930,WO06028. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to an assembly error within the breathing circuit, their pressure output of the breathing circuit kit can be affected and have severe impact to the end user

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Percussionaire Corporation
Distributor
US:AL AR CA CT FL GA IL IN KS LA MI MN MO NC NJ OH OR TN TX UT VA OUS: None
Lot
UDI: (01)10849436000331/Lot # WO05216, WO05254, WO05321, WO05392, WO05559, WO05588, WO05684, WO05749, WO05896, WO05930,WO06028
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was High Frequency Transport Phasitron Breathing Circuit Kit REF: A50605-D, Rx Only, CE 0123 recalled?

Yes. FDA published recall Z-0637-2024 on January 24, 2024. Reported hazard: Due to an assembly error within the breathing circuit, their pressure output of the breathing circuit kit can be affected and have severe impact to the end user

What should I do if I have this product?

Voluntary: Firm initiated · Letter